![Tasuku Kitada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Tasuku Kitada
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Strand Therapeutics, Inc.
![]() Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 31-10-2017 | - |
Hoofd Techniek/Wetenschap/O&O | 31-10-2017 | - | |
Oprichter | 31-10-2017 | - | |
President | 31-10-2017 | - | |
Bedrijfssecretaris | 31-10-2017 | - |
Loopbaan van Tasuku Kitada
Eerdere bekende functies van Tasuku Kitada
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Candriam Belgium SA
![]() Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Analyst-Equity | 01-01-2015 | - |
Statistieken
Internationaal
België | 2 |
Verenigde Staten | 2 |
Operationeel
Analyst-Equity | 1 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Candriam Belgium SA
![]() Candriam Belgium SA Investment ManagersFinance Candriam Belgium SA (Candriam) is the Belgian asset management subsidiary of Candriam Luxembourg SCA, ultimately held by New York Life Insurance Co. in the US. Founded in 1998, the firm was formerly known as Dexia Asset Management Belgium SA, the asset management division of Dexia SA (XB: DEXB). In 2014, New York Life Investments acquired Dexia Asset Management and the firm changed their name to Candriam, which is an acronym of their core values: “Conviction and Responsibility in Asset Management”. Headquartered in Brussels, Candriam provides discretionary and non-discretionary investment advisory services to US registered funds, a limited number of US natural persons, and to institutions. | Finance |
Strand Therapeutics, Inc.
![]() Strand Therapeutics, Inc. BiotechnologyHealth Technology Strand Therapeutics, Inc. develops genetically programming mRNA therapeutics. The company was founded by Tasuku Kitada, Darrell J. Irvine, Ron Weiss, and Jacob Becraft and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Tasuku Kitada
- Ervaring